Cargando…

Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers

BACKGROUND: Pulmonary hypertension (PH) in dogs is a syndrome that could be primary or secondary due to pulmonary disease, pulmonary thromboembolism, heartworm disease, and heart failure. Due to the inability of right heart catheterization in veterinary patients, there is a lack of differential crit...

Descripción completa

Detalles Bibliográficos
Autores principales: Oleynikov, Dmitrij Arkadievich, Yi, Ma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of Veterinary Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473372/
https://www.ncbi.nlm.nih.gov/pubmed/36118731
http://dx.doi.org/10.5455/OVJ.2022.v12.i4.8
_version_ 1784789486512635904
author Oleynikov, Dmitrij Arkadievich
Yi, Ma
author_facet Oleynikov, Dmitrij Arkadievich
Yi, Ma
author_sort Oleynikov, Dmitrij Arkadievich
collection PubMed
description BACKGROUND: Pulmonary hypertension (PH) in dogs is a syndrome that could be primary or secondary due to pulmonary disease, pulmonary thromboembolism, heartworm disease, and heart failure. Due to the inability of right heart catheterization in veterinary patients, there is a lack of differential criteria between PH forms. In some acute cases, it is impossible to provide a full EchoCG or catheterization study. In this situation, circulating markers may be useful to discover the possible mechanism of PH form and provide specific therapy. AIM: Following all previous data in human and veterinary studies, we assumed that plasm concentration of serotonin, endothelin-1 (ET-1), and vascular endothelial growth factor D (VEGF-D) would show a predominance in affected part of pulmonary circulation. METHODS: We studied 59 small-breed dogs of different sexes and ages. Groups were formed according to a primary pathology: healthy dogs (n = 8); dogs with myxomatous mitral valve disease (MMVD) and postcapillary PH (PostPH, n = 23); dogs with MMVD and precapillary PH (PrePH, n = 28). Animals in the study were diagnosed with the primary disease by standard echocardiographic methods and algorithms. Blood samples were collected at the moment of presentation and frozen in a −80°C fridge. For biochemistry analysis, we used species-specific ELISA kits, provided by Cloud-Clone Corp. (USA). The tests were provided by the means of Almazov National Medical Research Center, IEM laboratory. RESULTS: Dogs with EchoCG-proved PostPH had a higher concentration of VEGF-D in comparison to control and PrePH (р <0.001, for both). There was no difference between the control and PrePH groups (р >0.05). ET-1 was higher in PrePH in comparison to PostPH and control dogs (р <0.001, for both). In addition, there was no difference between the control and PostPH groups (р >0.05). Serotonin concertation did not have a difference between controls and PostPH. However, it was higher in PrePH than in control (р <0.033) and PostPH group (р <0.006). Receiver operating curve analysis showed that plasma concentrations of ET-1 (0.99) and VEGF-D (0.92) had high effectiveness in the differentiation of PostPH and PrePH. CONCLUSION: This study showed a correlation between circulating biomarkers (serotonin, ET-1, and VEGF-D). We found a connection between ET-1 and right-sided heart failure as well as VEGF-D and left heart failure in the PH context.
format Online
Article
Text
id pubmed-9473372
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Faculty of Veterinary Medicine
record_format MEDLINE/PubMed
spelling pubmed-94733722022-09-16 Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers Oleynikov, Dmitrij Arkadievich Yi, Ma Open Vet J Original Research BACKGROUND: Pulmonary hypertension (PH) in dogs is a syndrome that could be primary or secondary due to pulmonary disease, pulmonary thromboembolism, heartworm disease, and heart failure. Due to the inability of right heart catheterization in veterinary patients, there is a lack of differential criteria between PH forms. In some acute cases, it is impossible to provide a full EchoCG or catheterization study. In this situation, circulating markers may be useful to discover the possible mechanism of PH form and provide specific therapy. AIM: Following all previous data in human and veterinary studies, we assumed that plasm concentration of serotonin, endothelin-1 (ET-1), and vascular endothelial growth factor D (VEGF-D) would show a predominance in affected part of pulmonary circulation. METHODS: We studied 59 small-breed dogs of different sexes and ages. Groups were formed according to a primary pathology: healthy dogs (n = 8); dogs with myxomatous mitral valve disease (MMVD) and postcapillary PH (PostPH, n = 23); dogs with MMVD and precapillary PH (PrePH, n = 28). Animals in the study were diagnosed with the primary disease by standard echocardiographic methods and algorithms. Blood samples were collected at the moment of presentation and frozen in a −80°C fridge. For biochemistry analysis, we used species-specific ELISA kits, provided by Cloud-Clone Corp. (USA). The tests were provided by the means of Almazov National Medical Research Center, IEM laboratory. RESULTS: Dogs with EchoCG-proved PostPH had a higher concentration of VEGF-D in comparison to control and PrePH (р <0.001, for both). There was no difference between the control and PrePH groups (р >0.05). ET-1 was higher in PrePH in comparison to PostPH and control dogs (р <0.001, for both). In addition, there was no difference between the control and PostPH groups (р >0.05). Serotonin concertation did not have a difference between controls and PostPH. However, it was higher in PrePH than in control (р <0.033) and PostPH group (р <0.006). Receiver operating curve analysis showed that plasma concentrations of ET-1 (0.99) and VEGF-D (0.92) had high effectiveness in the differentiation of PostPH and PrePH. CONCLUSION: This study showed a correlation between circulating biomarkers (serotonin, ET-1, and VEGF-D). We found a connection between ET-1 and right-sided heart failure as well as VEGF-D and left heart failure in the PH context. Faculty of Veterinary Medicine 2022 2022-07-14 /pmc/articles/PMC9473372/ /pubmed/36118731 http://dx.doi.org/10.5455/OVJ.2022.v12.i4.8 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Oleynikov, Dmitrij Arkadievich
Yi, Ma
Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers
title Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers
title_full Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers
title_fullStr Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers
title_full_unstemmed Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers
title_short Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers
title_sort pre- and postcapillary pulmonary hypertension in dogs: circulating biomarkers
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473372/
https://www.ncbi.nlm.nih.gov/pubmed/36118731
http://dx.doi.org/10.5455/OVJ.2022.v12.i4.8
work_keys_str_mv AT oleynikovdmitrijarkadievich preandpostcapillarypulmonaryhypertensionindogscirculatingbiomarkers
AT yima preandpostcapillarypulmonaryhypertensionindogscirculatingbiomarkers